The Readout Loud
Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
What's on tap for Roche and its closely followed cancer immunotherapy? Are we all headed for another jab with a Covid-19 vaccine? And what explains the recent success of Vertex Pharmaceuticals' R&D pipeline?
This week, reporter Andrew Joseph joins us to discuss the FDA and its meeting with outside advisers that considered questions about Covid-19 boosters and the potential for updated vaccines that better match the circulating strains of SARS-CoV-2. We'll also dive into a look at Vertex and hear from its top executives about two experimental, but potentially groundbreaking, treatments for pain and type 1 diabetes. And as we often do, we’ll kick off the podcast with a Chatty Cathy round of hot takes on this week’s news.